Francoise Barre-Sinoussi
24Patents
5h-index
44Co-inventors
69Inventor score
Filing activity: Oct 8, 1985 → Apr 24, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4708818A | Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor | Emerging Cross-Sectional Technologies | 145 | Expired |
| US6395495B1 | Methods and kits for detecting antibodies against an HIV variant | Chemistry; Metallurgy | 24 | Expired |
| US5135864A | Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6627395B1 | Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1) | Physics | 7 | Expired |
| US4759929A | Novel treatment | Human Necessities | 5 | Expired |
| US5407811A | Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5173400A | Antibody detection of antibodies to viral proteins in serum | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7232654B1 | DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) | Chemistry; Metallurgy | 4 | Expired |
| US7217508B1 | Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) | Chemistry; Metallurgy | 4 | Expired |
| US5217861A | Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7030234B2 | Non-M, non-O HIV-1 strains, fragments and uses | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7205102B1 | Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA | Chemistry; Metallurgy | 4 | Expired |
| US6440657B1 | Nucleic acids and peptides of human immunodeficiency virus type (HIV-1) | Chemistry; Metallurgy | 3 | Expired |
| US5374519A | Oligopeptides comprising p18 protein of human immunodeficiency virus (HIV), compositions comprising peptides of p18 protein of HIV, and diagnostic kits and methods for detecting acquired immune deficiency syndrome (AIDS) | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5843638A | Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1). | Chemistry; Metallurgy | 3 | Expired |
| US6428952B1 | Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies | Physics | 3 | Expired |
| US6600023B1 | Antibody directed against HIV-1 P25 antigen | Physics | 2 | Expired |
| US4956292A | Viral strain isolated from cerebrospinal fluid of an HIV seropositive man having acute and regressive encephalopathy and use of the strain in an immunoassay | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7122188B1 | Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1 | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5610035A | Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies | Chemistry; Metallurgy | 2 | Expired |
| US6509018B1 | Non-M non-O HIV strains, fragments and uses | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5393744A | Glucosyl phosphotriesters of thymidine | Chemistry; Metallurgy | 1 | Expired |
| US7534877B2 | Non-M, non-O HIV-1 strains, fragments and uses | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8227185B2 | Non-M, non-O HIV-1 strains, fragments and uses | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.